Quogue Capital LLC 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-19 5:19 pm Purchase |
2024-02-20 | 13D | Iovance Biotherapeutics, Inc. IOVA |
Quogue Capital LLC | 30,000,000 11.600% |
5,000,000 (+20.00%) |
Filing |
| 2023-10-27 4:24 pm Purchase |
2023-09-15 | 13D | Iovance Biotherapeutics, Inc. IOVA |
Quogue Capital LLC | 25,000,000 15.840% |
5,000,000 (+25.00%) |
Filing |
| 2023-01-13 4:32 pm Purchase |
2022-12-02 | 13D | Iovance Biotherapeutics, Inc. IOVA |
Quogue Capital LLC | 20,000,000 13.000% |
11,000,000 (+122.22%) |
Filing |